Extracellular matrix mediates a molecular balance between vascular morphogenesis and regression

Current Opinion in Hematology

Volumn 15, Issue 3, 2008, Pages 197-203

  Davis, George E ^a,c   Senger, Donald R ^b  

^a University of Missouri   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

Collagen; Extracellular matrix; Fibronectin; Integrins; Matrix metalloproteinases; Regression; Thrombospondin; Tissue inhibitor of metalloproteinases; Vascular morphogenesis

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; CD47 ANTIGEN; INTERSTITIAL COLLAGENASE; LAMININ; RHO KINASE; STROMELYSIN 2; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

CELL FUNCTION; CELL INTERACTION; CELL SHAPE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; MORPHOGENESIS; NONHUMAN; PERICYTE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VASCULARIZATION;

CELL COMMUNICATION; COLLAGEN; EXTRACELLULAR MATRIX; HUMANS; MATRIX METALLOPROTEINASES; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION;

EID: 41949117906     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e3282fcc321     Document Type: Review

References (70)

1. Lammert E, Cleaver O, Melton D. Role of endothelial cells in early pancreas and liver development. Mech Dev 2003; 120:59-64.
2. Nikolova G, Jabs N, Konstantinova I, et al. The vascular basement membrane: a niche for insulin gene expression and Beta cell proliferation. Dev Cell 2006; 10:397-405.
3. Nikolova G, Strilic B, Lammert E. The vascular niche and its basement membrane. Trends Cell Biol 2007; 17:19-25.
4. Yamada KM, Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell 2007; 130:601-610.
5. Bell SE, Mavila A, Salazar R, et al. Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling. J Cell Sci 2001; 114:2755-2773.
6. Davis GE, Bayless KJ, Mavila A. Molecular basis of endothelial cell morphogenesis in three-dimensional extracellular matrices. Anat Rec 2002; 268:252-275.
7. Davis GE, Saunders WB. Molecular balance of capillary tube formation versus regression in wound repair: role of matrix metalloproteinases and their inhibitors. J Investig Dermatol Symp Proc 2006; 11:44-56.
8. Davis GE, Senger DR. Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res 2005; 97:1093-1107.
9. Hynes RO. Cell-matrix adhesion in vascular development. J Thromb Haemost 2007; 5 (Suppl 1):32-40.
10. Rhodes JM, Simons M. The extracellular matrix and blood vessel formation: not just a scaffold. J Cell Mol Med 2007; 11:176-205.
11. Scheele S, Nystrom A, Durbeej M, et al. Laminin isoforms in development and disease. J Mol Med 2007; 85:825-836.
12. Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 2007; 8:464-478.
13. Bryan BA, D'Amore PA. What tangled webs they weave: Rho-GTPase control of angiogenesis. Cell Mol Life Sci 2007; 64:2053-2065.
14. Hoang MV, Whelan MC, Senger DR. Rho activity critically and selectively regulates endothelial cell organization during angiogenesis. Proc Natl Acad Sci U S A 2004; 101:1874-1879.
15. Davis GE, Camarillo CW. An alpha 2 beta 1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix. Exp Cell Res 1996; 224:39-51.
16. Bayless KJ, Davis GE. The Cdc42 and Rac1 GTPases are required for capillary lumen formation in three-dimensional extracellular matrices. J Cell Sci 2002; 115:1123-1136.
17. Liu Y, Senger DR. Matrix-specific activation of Src and Rho initiates capillary morphogenesis of endothelial cells. Faseb J 2004; 18:457-468.
18. Koh W, Mahan RD, Davis GE. Cdc42 and Rac1-mediated endothelial lumen formation requires Pak2, Pak4, Par3, and Protein Kinase C-dependent signaling. J Cell Sci 2008; 121:989-1001.
19. Hallmann R, Horn N, Selg M, et al. Expression and function of laminins in the embryonic and mature vasculature. Physiol Rev 2005; 85:979-1000.
20. Pollard SM, Parsons MJ, Kamei M, et al. Essential and overlapping roles for laminin alpha chains in notochord and blood vessel formation. Dev Biol 2006; 289:64-76.
21. Jakobsson L, Domogatskaya A, Tryggvason K, Edgar D, Claesson-Welsh L. Laminin deposition is dispensable for vasculogenesis but regulates blood vessel diameter independent of flow. Faseb J (in press).
22. Miner JH, Yurchenco PD. Laminin functions in tissue morphogenesis. Annu Rev Cell Dev Biol 2004; 20:255-284.
23. Thyboll J, Kortesmaa J, Cao R, et al. Deletion of the laminin alpha4 chain leads to impaired microvessel maturation. Mol Cell Biol 2002; 22:1194-1202.
24. Saunders WB, Bohnsack BL, Faske JB, et al. Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3. J Cell Biol 2006; 175:179-191.
25. Davis GE, Pintar Allen KA, Salazar R, Maxwell SA. Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices. J Cell Sci 2001; 114:917-930.
26. Yana I, Sagara H, Takaki S, et al. Crosstalk between neovessels and mural cells directs the site-specific expression of MT1-MMP to endothelial tip cells. J Cell Sci 2007; 120:1607-1614.
27. Chun TH, Sabeh F, Ota I, et al. MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix. J Cell Biol 2004; 167:757-767.
28. Saunders WB, Bayless KJ, Davis GE. MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices. J Cell Sci 2005; 118:2325-2340.
29. Chang S, Young BD, Li S, et al. Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell 2006; 126:321-334.
30. Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res 2005; 97:512-523.
31. von Tell D, Armulik A, Betsholtz C. Pericytes and vascular stability. Exp Cell Res 2006; 312:623-629.
32. Ramsauer M, D'Amore PA. Contextual role for angiopoietins and TGFbeta1 in blood vessel stabilization. J Cell Sci 2007; 120:1810-1817.
33. Stetler-Stevenson WG, Seo DW. TIMP-2: an endogenous inhibitor of angiogenesis. Trends Mol Med 2005; 11:97-103.
34. Seo DW, Li H, Guedez L, et al. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell 2003; 114:171-180.
35. Qi JH, Ebrahem Q, Moore N, et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 2003; 9:407-415.
36. Mundel TM, Kalluri R. Type IV collagen-derived angiogenesis inhibitors. Microvasc Res 2007; 74:85-89.
37. Folkman J. Tumor suppression by p53 is mediated in part by the antiangiogenic activity of endostatin and tumstatin. Sci STKE 2006, 2006:pe35.
38. Davis GE, Bayless KJ, Davis MJ, Meininger GA. Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules. Am J Pathol 2000; 156:1489-1498.
39. Abdollahi A, Hahnfeldt P, Maercker C, et al. Endostatin's antiangiogenic signaling network. Mol Cell 2004; 13:649-663.
40. Roth JM, Akalu A, Zelmanovich A, et al. Recombinant alpha2(IV)NC1 domain inhibits tumor cell-extracellular matrix interactions, induces cellular senescence, and inhibits tumor growth in vivo. Am J Pathol 2005; 166:901-911.
41. Bix G, Fu J, Gonzalez EM, et al. Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through alpha2beta1 integrin. J Cell Biol 2004; 166:97-109.
42. Bix G, Castello R, Burrows M, et al. Endorepellin in vivo: targeting the tumor vasculature and retarding cancer growth and metabolism. J Natl Cancer Inst 2006; 98:1634-1646.
43. Lee S, Jilani SM, Nikolova GV, et al. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol 2005; 169:681-691.
44. Mancuso MR, Davis R, Norberg SM, et al. Rapid vascular regrowth in tumors after reversal of VEGF inhibition. J Clin Invest 2006; 116:2610-2621.
45. Ridnour LA, Isenberg JS, Espey MG, et al. Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1. Proc Natl Acad Sci U S A 2005; 102:13147-13152.
46. Isenberg JS, Wink DA, Roberts DD. Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses. Cardiovasc Res 2006; 71:785-793.
47. Isenberg JS, Ridnour LA, Dimitry J, et al. CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J Biol Chem 2006; 281:26069-26080.
48. Isenberg JS, Hyodo F, Pappan LK, et al. Blocking thrombospondin-1/CD47 signaling alleviates deleterious effects of aging on tissue responses to ischemia. Arterioscler Thromb Vasc Biol 2007; 27:2582-2588.
49. Isenberg JS, Romeo MJ, Yu C, et al. Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling. Blood 2008; 111:613-623. TSP-1 represents a major secreted product of platelets and this new study provides important new insight into why this is so. The ability of TSP-1 to interfere with nitric oxidemediated signaling allowsplatelets to acutely and locally antagonize nitric oxide mediated dilation and inhibitory effects on adhesion receptor function, thus, leading to increased platelet aggregation and prothrombotic activities.
50. Lucitti JL, Jones EA, Huang C, et al. Vascular remodeling of the mouse yolk sac requires hemodynamic force. Development 2007; 134:3317-3326.
51. Greene AS, Tonellato PJ, Lui J, et al. Microvascular rarefaction and tissue vascular resistance in hypertension. Am J Physiol 1989; 256:H126-H131.
52. Isenberg JS, Pappan LK, Romeo MJ, et al. Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts. Ann Surg 2008; 247:180-190. This is a very interesting study showing the powerful influence of TSP-1 signaling pathways on graft survival. This work has important implications for the response of tissues to ischemia and how vessels react to hypoxia stimuli and recover from these injuries.
53. Schwartz MA, Shattil SJ. Signaling networks linking integrins and rho family GTPases. Trends Biochem Sci 2000; 25:388-391.
54. Mavria G, Vercoulen Y, Yeo M, et al. ERK-MAPK signaling opposes Rho-kinase to promote endothelial cell survival and sprouting during angiogenesis. Cancer Cell 2006; 9:33-44.
55. Bayless KJ, Davis GE. Microtubule depolymerization rapidly collapses capillary tube networks in vitro and angiogenic vessels in vivo through the small GTPase Rho. J Biol Chem 2004; 279:11686-11695.
56. Im E, Kazlauskas A. Src family kinases promote vessel stability by antagonizing the Rho/ROCK pathway. J Biol Chem 2007; 282:29122-29129. This very nice study extends previouswork showing the involvement of ERK signaling in promoting vessel stability and identifies Src family kinases as also playing a key role in conjunction with ERK for inactivating Rho/Rho kinase tomaintain the integrity of the vascular wall.
57. Bayless KJ, Salazar R, Davis GE. RGD-dependent vacuolation and lumen formation observed during endothelial cell morphogenesis in three-dimensional fibrin matrices involves the alpha(v)beta(3) and alpha(5)beta(1) integrins. Am J Pathol 2000; 156:1673-1683.
58. Carnevale E, Fogel E, Aplin AC, et al. Regulation of postangiogenic neovessel survival by beta1 and beta3 integrins in collagen and fibrin matrices. J Vasc Res 2007; 44:40-50.
59. Serini G, Valdembri D, Bussolino F. Integrins and angiogenesis: a sticky business. Exp Cell Res 2006; 312:651-658.
60. Robins SP. Biochemistry and functional significance of collagen cross-linking. Biochem Soc Trans 2007; 35:849-852.
61. Zhang Z, Ramirez NE, Yankeelov TE, et al. {alpha}2{beta}1 integrin expression in the tumor microenvironment enhances tumor angiogenesis in a tumor-cell specific manner. Blood 2008; 111:1980-1988.
62. Zweers MC, Davidson JM, Pozzi A, et al. Integrin alpha2beta1 is required for regulation of murine wound angiogenesis but is dispensable for reepithelialization. J Invest Dermatol 2007; 127:467-478.
63. Gardner H, Broberg A, Pozzi A, et al. Absence of integrin alpha1beta1 in the mouse causes loss of feedback regulation of collagen synthesis in normal and wounded dermis. J Cell Sci 1999; 112 (Pt 3):263-272.
64. Senger DR, Perruzzi CA, Streit M, et al. The alpha(1)beta(1) and alpha(2)-beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. Am J Pathol 2002; 160:195-204.
65. Senger DR, Claffey KP, Benes JE, et al. Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc Natl Acad Sci U S A 1997; 94:13612-13617.
66. Francis SE, Goh KL, Hodivala-Dilke K, et al. Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler Thromb Vasc Biol 2002; 22:927-933.
67. Garmy-Susini B, Jin H, Zhu Y, et al. Integrin alpha4beta1-VCAM-1- mediated adhesion between endothelial and mural cells is required for blood vessel maturation. J Clin Invest 2005; 115:1542-1551.
68. Mishima K, Watabe T, Saito A, et al. Prox1 induces lymphatic endothelial differentiation via integrin alpha9 and other signaling cascades. Mol Biol Cell 2007; 18:1421-1429.
69. Astrof S, Crowley D, Hynes RO. Multiple cardiovascular defects caused by the absence of alternatively spliced segments of fibronectin. Dev Biol 2007; 311:11-24. This is an important new study which begins to characterize the unique nature of the embryonic ECM environment and identifies requirements for fibronectin during cardiovascular development. It also implicates an important and required role for fibronectins in early vascular assembly, perivascular cell recruitment as well as vascular remodeling events. This type of work will lead to new insights into how the unique signals delivered from embryonic matrices control vascular development and how this ultimately will be distinct or show similarities in the context of various disease states.
70. Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 2004; 4:528-539.